Inborn errors of metabolism
a clinical overview
Keywords:
Inborn errors of metabolism, Metabolic inherited disease, DiagnosisAbstract
CONTEXT: Inborn errors of metabolism cause hereditary metabolic diseases (HMD) and classically they result from the lack of activity of one or more specific enzymes or defects in the transportation of proteins. OBJECTIVES: A clinical review of inborn errors of metabolism (IEM) to give a practical approach to the physician with figures and tables to help in understanding the more common groups of these disorders. DATA SOURCE: A systematic review of the clinical and biochemical basis of IEM in the literature, especially considering the last ten years and a classic textbook (Scriver CR et al, 1995). SELECTION OF STUDIES: A selection of 108 references about IEM by experts in the subject was made. Clinical cases are presented with the peculiar symptoms of various diseases. DATA SYNTHESIS: IEM are frequently misdiagnosed because the general practitioner, or pediatrician in the neonatal or intensive care units, does not think about this diagnosis until the more common cause have been ruled out. This review includes inheritance patterns and clinical and laboratory findings of the more common IEM diseases within a clinical classification that give a general idea about these disorders. A summary of treatment types for metabolic inherited diseases is given. CONCLUSIONS: IEM are not rare diseases, unlike previous thinking about them, and IEM patients form part of the clientele in emergency rooms at general hospitals and in intensive care units. They are also to be found in neurological, pediatric, obstetrics, surgical and psychiatric clinics seeking diagnoses, prognoses and therapeutic or supportive treatment.
Downloads
References
Dronamraju K. Biography - Profiles in genetics: Archibald E. Garrod (1857-1936). Am J Hum Genet 1992;51:216-9.
Scriver CR. Foreword In: Blau N, Duran M, Blaskovics ME. Physician's guide to the laboratory diagnosis of metabolic diseases. Oxford, UK: Chapman & Hall; 1996.
Waber L. Inborn errors of metabolism. Ped Ann 1990;19(2):105-17.
Wappner RS. Biochemical diagnosis of genetic diseases. Ped Ann 1993;22(5):282-97.
Saudubray JM, Charpentier C. Clinical phenotypes: Diagnosis/Algorithms. In: Scriver CR, Beaudet AL, Sly W, Valle D. The metabolic and molecular bases of inherited disease, 7th edition. McGraw-Hill; 1995.
Lindor NM, Karnes PS. Laboratory medicine and pathology: initial assessment of infants and children with suspected inborn errors of metabolism. Mayo Clin Proc 1995;70:987-8.
Wilcox WR. Inborn errors of metabolism. Online copyright (C) 1995 - World Wide Web URL: http://www.wwilcox@mailgate.csmc.edu
Walter J. How to recognize inborn errors of metabolism. The Practitioner 1995; 239:321-325.
Martins AM, Fisberg RM, Schmidt BJ. Estudio clinico de nińos brasilenos con fenilcetonuria, seguimiento a 5 ańos. Actualidad Nutricional 1995;21(2):66-70.
Seymour CA, Thomason MJ, Chalmers RA, et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess 1997;1(11):1-95.
Schmidt BJ, Martins AM, Fisberg RM, Müller R, Adell ACA, Subero EM. Fenilquetonuria: aspectos clínicos y terapéuticos. Pediatria al Dia 1987;3(5):256-7.
Camargo Neto E, Schulte J, Silva, LCS, Giugliani R. Cromatografia em camada delagada para a detecçăo neonatal de fenilcetonúria e outras aminoacidopatias. Rev Bras Anál Clín 1993;25(3):81-2.
Pinto ALR, Raymond KM, Bruck I, Antoniuk SA. Estudo de prevalęncia em recém-nascidos por defeicięncia de biotinidase. Rev Saúde Pública 1998;32(2):148-52.
Scriver CR, Beaudet AL, Sly W, Valle D. The Metabolic and Molecular Bases of Inherited Disease, 7th edition. McGraw-Hill; 1995.
Sperl W, Geiger R, Lehnert W, Rhead W. Stridor as the major presenting symptom in riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Eur J Pediatr 1997;156:800-2.
Carmant L, Decarie JC, Fon E, Shevell MI. Transient visual symptoms as the initial manifestation of childhood adrenoleukodystrophy. Pediatr Neurol 1998;19(1):62-4.
Burton BK. Inborn errors of metabolism: The clinical diagnosis in early infancy. Pediatrics 1987;79(3):359-69.
Clayton PT, Thompson E. Dysmorphic syndromes with demonstrable biochemical abnormalities. J Med Genet, 1988;25:463-72.
Seashore MR, Rinaldo P. Metabolic disease of the neonate and young infant. Semin Perinatol 1993;17(5):318-29.
Ris MD, Williams SE, Hunt MM, HK Berry, Leslie N. Early treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 1994;124(3):388-92.
Ris MD, Weber AM, Hunt MM, Berry HK, Williams SE, Leslie N. Adult psychosocial outcome in early-treated phenylketonuria. J Inherit Metab Dis 1997;20(4):499-508.
McDonnell GV, Esmonde TF, Hadden DR, Morrow, JI. A neurological evaluation of adult phenylketonuria in Northern Ireland. Eur Neurol 1998;39(1):38-43.
Cordero VC, Ayastuy IG, Andonegui GMS, et al. Increased survival rates of children with cystic fibrosis. An Esp Pediatr 1990;32(5):407-12.
Levy HL. Maternal phenylketonuria. Review with emphasis on pathogenesis. Enzyme 1987;38(1-4):312-20.
Acosta PB, Wright L. Nurse's role in preventing birth defects in offspring of women with phenylketonuria. J Obstet Gynecol Neonatal Nurs 1992;21(4):270-6.
Friedman EG, Koch R, Azen C, et al. The international collaborative study on maternal phenylketonuria: organization, study design and description of the sample. Eur J Pediatr 1996;155 (Suppl 1): S158-61.
Cipcic-Schmidt S, Trefz FK, Funders B, Seidlitz G, Ullrich K. German maternal phenylketonuria study. Eur J Pediatr 1996;155 (Suppl 1):S173-6.
Brenton DP, Lindburn M. Maternal phenylketonuria. A study from the United Kingdom. Eur J Pediatr 1996; 155 (Suppl 1):S177-80.
Koch R, Levy H, Hanley W, et al. Outcome implications of the international maternal phenylketonuria collaborative study (MPKUCS): 1994. Eur J Pediatr 1996;155 (Suppl 1): S162-4.
Michals K, Acosta PB, Austin V, et al. Nutrition and reproductive outcome in maternal phenylketonuria. Eur J Pediatr 1996;155 (Suppl 1):S165-8.
Jardim LB, Palma-Dias R, Silva LC, Ashton-Prolla P, Giugliani R. Maternal hyperphenylalaninemia as a cause of microcephaly and mental retardation. Acta Paediatr 1996;85(8):943-6.
Levy HL, Waisbren SE, Lobbregt D et al. Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr 1996;155 (Suppl 1):S20-5.
Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen storage disease. N Engl J Med 1984;310:171-3.
Talent GM, Coleman RA, Alter C, Baker L et al. Glycogen storage disease in adults. Ann Intern Med 1994;120(3):218-26.
Lee PJ, Leonard JV. The hepatic glycogen storage disease - problems beyond childhood. J Inherit Metab Dis 1995;18(4):462-72.
Sethi KD, Ray R, Roesel RA, et al. Adult-onset chorea and dementia with propionic acidemia. Neurology 1989;39:1343-5.
Lameire N, Mussche M, Baele G, Kint J, Ringoir S. Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med 1978;65:416-23.
Peaston MJ. Dangers of intravenous fructose. Lancet 1973;1(7797):266.
Collins J. Metabolic disease: time for fructose solutions to go. Lancet 1993;34(8845):600.
Burmeister LA, Vaidivia T, Nuttall FQ. Adult hereditary fructose intolerance. Arch Intern Med 1991;151(4):773-6.
Couper R. Hereditary fructose intolerance in an adult. Aust N Z J Med 1996;26(2):231.
Cox TM. Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child 1993;69(4):413-5.
Rowe PC, Newman SL, Brusilow SW. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 1986;314(9):541-7.
Arn PH, Hauser ER, Thomas GH, Herman G, Hess D, Brusilow SW. Hyperammonemia in women with a mutation at the ornithine carbamyltransferase locus. N Engl J Med 1990;322(23):1652-5.
Yoshino M, Nishiyori J, Yamashita F, et al. Ornithine transcarbamylase deficiency in male adolescence and adulthood. Enzyme 1990;43(3):160-8.
Wilson BE, Hobbs WN, Newmark JJ, Farrow SJ. Rapidly fatal hyperammonemic coma in adults: urea cycle enzyme deficiency. West J Med 1994;161:166-8.
Shaw PJ, Dale G, Bates D. Familial lysinuric protein intolerance presenting as coma in two adult siblings. J Neurol Neurosurg Psychiatry 1989;52(5):648-51.
Albers SE, Brozena SJ, Glass LF, Fenske, NA. Alkaptonuria and ochronosis: case report and review. J Am Acad Dermatol 1992;27(4):609-14.
Koh KB, Low EH, Ch'ng SL, Zakiah I. A case of alkaptonuria with root canal stenosis. Singapore Med J 1994;35(1):106-7.
Reddy DR, Prasad VS. Alkaptonuria presenting as lumbar disc prolapse: case report and review of literature. Spinal Cord 1998;36(7):523-4.
Dusheiko G, Kew MC, Joffe BI, et al. Recurrent hypoglycemia associated with glutamic aciduria type II in an adult. N Engl J Med 1979;301(26):1405-9.
Pears JS, Jung RT, Hopwood, D, Waddell ID, Burchell A . Glycogen storage disease diagnosed in adults. Q J Med 1992;82(299):207-22.
Burchell A, Jung RT, Lang CC, Bennet W, Shepherd A . Diagnosis of type 1A and type 1C glycogen storage disease in adults. Lancet 1987;1(8541):1059-62.
Kurz D, Aguzzi A, Scherer TA . Decompensated cor pulmonalea: the first manifestation of adult-onset myopathy. Respiration 1998;65(4):317-9.
Cinnamon J, Slonim AE, Black KS, Gorey MT, Scuderi DM, Hyman RA. Evaluation of the lumbar spine in patients with glycogen storage disease: CT demonstration of patterns of paraspinal muscle atrophy. Am J Neuroradiol 1991;12(6):1099- 103.
Puig JG, de Miguel E, Mateos FA, et al. McArdle's disease and gout. Muscle Nerve 1992;15(7):822-8.
Felice KJ, Schneebaum AB, Jones HR. McArdle's disease with late-onset symptoms: case report and review of the literature. J Neurol Neurosurg Psychiatry 1992;55(5):407-8.
Chiado-Piat L, Mongini T, Doriguzzi C, Maniscalco M, Palmucci, L. Clinical spectrum of McArdle's disease: three cases with unusual expression. Eur Neurol 1993;33(3):208-11.
Thornhill MH. Masticatory muscle symptoms in a patient with McArdle's disease. Oral Surg Oral Med Pathol Oral Radiol Endod 1996;81(5):544-6.
Nicholls DP, Campbell NP, Stevenson HP, Patterson VH. Angina in McArdle's disease. Heart 1996;76(4):372-3.
Olmos JM, Zarrabeitia MT, Valero MC, Figols J, Matorras P, Riancho JA. McArdle's disease in adults: clinical and genetic study. Med Clin (Barc) 1997;109(19):753-5.
Navon R, Argov Z, Frisch A. Hexoaminidase a deficiency in adults. Am J Med Genet 1986;24:179-96.
Hurowitz GI, Silver JM, Brin MF, Williams DT, Johnson WG. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings. J Neuropsychiatry Clin Neurosci 1993;5(1):30-6.
Rosebush PI, MacQueen GM, Clarke JT, Callahan JW, Strasberg PM, Mazurek MF. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry 1995;56(8):347-53.
Hund E, Grau A, Fogel W, et al. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexoaminidase A deficiency with late clinical onset in four siblings. J Neurol Sci 1997;145(1):25-31.
MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1998;10(1):10-9.
Schlote W, Molzer B, Peiffer J et al. Adrenoleukodystrophy in an adult female: a clinical, morphological, and neurochemical study. J Neurol 19987;235(1):1-9.
De Andres C, Gimenez-Roldan S. Familial spastic paraparesis: phenotypic variant of adrenoleukodystrophy. Neurologia 1990;5(1):24-8.
Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Rev Neurosci 1991;13(4-5):254-61.
Ong BK, Lee KO, Lee T, Chong PN. An index case of adrenomyeloneuropathy in a Chinese man. Singapore Med J 1994;35(6):643-5.
Fitzgerald MA, Gross JB, Goldstein NP, Wahner HW, McCall JT. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. Mayo Clin Proc 1975,50(8):438-42.
Baban NK, Hubbs DT, Roy TM. Wilson's disease. South Med J 1997;90(5):535-8.
Bellary SV & Van Thiel DH. Wilson's disease: a diagnosis made in two individuals greater than 40 years of age. J Okla State Med Assoc 1993;86(9):441-4.
Turpin JC, Masson M, Bauman N. Clinical aspects of Nieman-Pick type C disease in adult. Dev Neurosci 1991;13(4-5):304-6.
Hulette CM, Earl NL, Anthony DC, Crain BJ. Adult onset Nieman-Pick disease type C presenting with dementia and absent organomegaly. Clin Neuropathol 1992;11(6):293-7.
Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA. Late-onset mitochondrial myopathy. Am Neurol 1995;37(1):16-23.
Kaido M, Fujimura H, Soga F, et al. Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neuropathol (Berl) 1996;92(3):312-8.
Malndrini A, Palmeri S, Fabrizi GM, et al. Juvenile Leigh syndrome with protracted course presenting chronic sensory motor neuropathy, ataxia, deafness and retinitis pigmentosa: a clinicopathological report. J Neurol Sci 1998;155(2):218-21.
Elleder M, Ledvinova J, Cieslar P, Kuhn R. Sub-clinical course of cholesterol ester storage (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process. Virchows Arch Pathol Anat Histopathol 1990;416(4):357-65.
Bauman N, Masson M, Carreau V, Lefevre M, Herschkowitz N, Turpin JC. Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Rev Neurosci 1991;13(4-5):211-15.
Flexner JM. Hemochromatosis: diagnosis and treatment. Compr Ther 1991;17(11):7-9.
Phatak PD, Cappuccio JD. Management of hereditary hemochromatosis. Blood Ver 1994;8(4):193-8.
Sveinbjornsdottir S, Blondal H, Gudmundsson G, Kjartansson O, Jonsdottir S, Gudmundsson G. Progressive dementia and leukoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopathological presentation of two cases. J Neurol Sci 1996;140(1-2):101-8.
Simon DK, Rodriguez ML, Frosh MP, Quackenbush EJ, Feske SK, Natowicz MR. A unique familial leukodystrophy with adult onset dementia and abnormal glycolipid storage: a new lysosomal disease? J Neurol Neurosurg Psychiatry 1998;65(2):251-4.
Blau N, Blaskovics ME, Duran M. Simple test in urine and blood, pp. 3-11. In: Blau, N, Duran M, Blaskovics ME. Physician' s guide to the laboratory diagnosis of metabolic diseases, 1st Edition. Oxford: Chapman & Hall Medical; 1996.
Buist N. Set of simple side-room urine tests of inborn errors of metabolism. Br Med J 1968;2:745-9.
Thomas GH, Howell RR. Selected screening tests for genetic metabolic diseases. Chicago, Year Book Medical Publishers; 1973.
Giorgio AJ, Luhby ALA. A rapid screening test for the detection of congenital methylmalonic aciduria in infancy. Am J Clin Pathol 1969;52:374-9.
Efron ML, Young D, Moser HW, MacCready RA. A simple chromatographic screening test for the detection of disorders of amino acid metabolism: a technique using whole blood or urine collected on filter paper. N Engl J Med 1964;270:1378-83.
Hoffman GF. Organic acid analysis. Part One C, pp. 31-49. In: Nenad B, Duran M, Blaskovics ME. Physician's guide to the diagnosis of metabolic diseases. Oxford: Chapman & Hall; 1996.
Shih VE. Amino acid analysis. Part 1B, pp. 13-29. In: Nenad B, Duran M, Blaskovics ME. Physician's guide to the diagnosis of metabolic diseases. Oxford: Chapman & Hall; 1996.
Stern HJ. Lactic acidosis in pediatrics: clinical and laboratory evaluation. Ann Clin Biochem 1994;31:410-9.
Ridaura-Sanz C. The pathologist's approach to the diagnosis of metabolic disease. Path Res Pract 1994;190:1109-22.
Dixon MA, Leonard JV. Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 1992;67:1387-9.
Champe PC, Harvey RA. Bioquímica Ilustrada. 2nd ed. Artes Médicas; 1996.
Harris RE, Leslie N, Krivit W. Lysosomal and peroxisomal storage disease, Part 6.11, pp. 275-285. In: Burrt RK, Deeg HJ, Lothian ST, Santos G. On call in: bone marrow transplantation. RG Landes Company; 1996.
McKinnis EJ, Sulzbacher S, Rutledge JC, Sanders J, Scott CR. Bone marrow transplantation in Hunter syndrome. J Pediatr 1996;129(1):145-8.
Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133(1):119-25.
Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The storage disease collaborative study group. Blood 1998;91(7):2601-8.
Beutler E, Demina A, Laubscher K , et al. The clinical course of treated and untreated Gaucher disease: a study of 45 patients. Blood Cells Mol Dis 1995;21(10):86-108.
Charrow J, Esplin JA, Grible TJ, et al. Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 1998;158(16):1754-60.
Damiano AM, Pastores GM, Ware JE Jr. The health-related quality of life adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study. Qual Life Res 1998;7(5):373-86.
Brooks DA, King BM, Crawley AC, Byers S, Hopwood JJ. Enzyme replacement therapy in mucopolysaccharodosis VI: Evidence for immune responses and altered efficacy of treatment in animal models. Biochim Biophys Acta 1997;1361(2):203-16.
O'Connor LH, Lawrence CE, Vogler CA, et al. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J Clin Invest 1998;101(7):1394-400.
